← Leaderboards
Roger Vincent Belizaire
Dana-Farber Cancer Inst
$1,076,976
Attributed
$1,076,976
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $269.2K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$1,076,976 · 1
By mechanism
K08$1,076,976 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Benjamin Levine Ebert$26,802,844
- Donald W. Kufe$50,160,456
- Jun Qi$6,834,111
- Jevon Cutler$711,818
- Jens G Lohr$2,586,070
Others in their field
Other Rising Stars on “Crispr Screen”
- Christopher W Peterson · Fred Hutchinson Cancer Center$3,006,188
- Yanling Wang · Rush University Medical Center$2,939,549
- Jellert Gaublomme · Columbia Univ New York Morningside$2,452,762
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Ruth Huttenhain · University Of California, San Francisco$2,364,012
- Xin Jin · Scripps Research Institute, The$2,265,169
Research focus
Crispr ScreenAdvisory CommitteesAcquired Drug ResistanceCrispr/Cas TechnologyBindingBiologicalBiologyAllelesAdaptor Signaling ProteinCareer DevelopmentCbl GeneCbl ProteinCell LineCell ProliferationCellsCell SurvivalChronic Myelomonocytic LeukemiaBone MarrowClinical PracticeCareerCollaborationsCombined Modality TherapyCommunitiesDana-Farber Cancer Institute
Grant awards (4)
Novel targeted therapies for chronic myelomonocytic leukemia$269,244
K08 · FY2025 · CA · contact PI
Novel targeted therapies for chronic myelomonocytic leukemia$269,244
K08 · FY2024 · CA · contact PI
Novel targeted therapies for chronic myelomonocytic leukemia$269,244
K08 · FY2023 · CA · contact PI
Novel targeted therapies for chronic myelomonocytic leukemia$269,244
K08 · FY2022 · CA · contact PI